- By ICR Secretariat
- Posted Tuesday, June 6, 2017
China is about to begin clinical trials on embryonic stem cells
Surgeons in Zhengzhou, China, will soon begin the first clinical trial of embryonic stem cells on parkinsons sufferers, injecting the stem cells directly into the patients brains. The scientific community is divided over whether the treatment is a good idea, however.